Related Experiment Video
Updated: Dec 31, 2025

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Ecm29-mediated proteasomal distribution modulates excitatory GABA responses in the developing brain.
Min Lee1, Yen-Chen Liu1, Chen Chen1
1Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan.
Neuronal development relies on proteasome distribution, regulated by Ecm29. This impacts chloride transporter NKCC1, GABAergic inhibition timing, and neuronal excitability during early postnatal development.
Area of Science:
- Neuroscience
- Cell Biology
- Developmental Biology
Background:
- Neuronal GABAergic responses mature from excitatory to inhibitory postnatally.
- Intracellular chloride concentrations control this switch, but factors influencing cation-chloride cotransporter levels are unclear.
Purpose of the Study:
- To investigate the role of proteasome distribution in regulating neuronal maturation and GABAergic inhibition timing.
- To identify molecular mechanisms controlling proteasome localization at the axon initial segment (AIS).
Main Methods:
- Utilized Ecm29 knockout (KO) mouse models.
- Investigated proteasome distribution, NKCC1 protein levels, and GABAergic response timing.
- Analyzed action potential firing frequency and seizure susceptibility.
- Examined AIS development and morphological plasticity.
Main Results:
- Ecm29 KO neurons showed increased NKCC1 density in the AIS, delaying the GABAergic switch.
- Ecm29 KO mice exhibited increased action potential firing and seizure susceptibility.
- AIS development was accelerated in Ecm29 KO neurons, indicating altered plasticity.
Conclusions:
- Neuronal maturation necessitates Ecm29-mediated regulation of proteasome distribution.
- Ecm29 controls NKCC1 localization and GABAergic inhibition timing via proteasome tethering to the AIS.
- Perturbed proteasome distribution impacts neuronal excitability and AIS development.
More Related Videos
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
07:51Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
Published on: November 14, 2014
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...